Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 2,030 shares of common stock on April 21, 2024, to satisfy tax withholding obligations.
Summary
- On April 21, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 2,030 shares of common stock.
- The transaction was executed at a price of $1.15 per share.
- This disposal was conducted to cover tax obligations related to equity compensation.
- Following the transaction, Christianson directly owns 323,204 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction to cover tax obligations, which is a routine occurrence.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment shifts.
Stakeholder Impact
- The disposal of shares by an insider could be perceived negatively by some shareholders, although it is a common practice to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 04/21/2024 | Date of transaction: Mark Christianson disposed of 2,030 shares of common stock. |
| 04/23/2024 | Date of signature: The Form 4 was signed on this date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.